Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 714

1.

Multidisciplinary treatment of gastrointestinal stromal tumors.

Kingham TP, DeMatteo RP.

Surg Clin North Am. 2009 Feb;89(1):217-33, x. doi: 10.1016/j.suc.2008.10.003. Review.

PMID:
19186237
2.

Molecular research directions in the management of gastrointestinal stromal tumors.

Tarn C, Godwin AK.

Curr Treat Options Oncol. 2005 Nov;6(6):473-86. Review.

PMID:
16242052
3.

[Study on the mechanism of imatinib-induced resistance in gastrointestinal stromal tumors].

Zhou Y, Hou YY, Tan YS, Lu SH, Hou J, Liu JL, Qin J, Shen KT, Sun YH.

Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):597-601. Chinese.

PMID:
20021947
4.

Secondary c-kit mutation in a recurrent gastrointestinal stromal tumor under long-term treatment with imatinib mesylate: report of a case.

Utsunomiya T, Okamoto M, Yano S, Kameyama T, Matsuyama A, Kuma S, Yamamoto M, Fujiwara M, Ishida T.

Surg Today. 2008;38(1):65-7. Epub 2007 Dec 24.

PMID:
18085368
5.

KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.

Loughrey MB, Trivett M, Beshay V, Dobrovic A, Kovalenko S, Murray W, Lade S, Turner H, McArthur GA, Zalcberg J, Waring PM.

Histopathology. 2006 Jul;49(1):52-65.

PMID:
16842246
6.

Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.

Yeh CN, Chen TW, Tseng JH, Liu YY, Wang SY, Tsai CY, Chiang KC, Hwang TL, Jan YY, Chen MF.

J Surg Oncol. 2010 Nov 1;102(6):599-603. doi: 10.1002/jso.21630.

PMID:
20976730
7.

Gastrointestinal stromal tumor: 5 years later.

van der Zwan SM, DeMatteo RP.

Cancer. 2005 Nov 1;104(9):1781-8. Review.

8.

A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.

Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, Lee WK, Kang HJ, Kang YK.

Oncology. 2009;76(5):326-32. doi: 10.1159/000209384. Epub 2009 Mar 23.

PMID:
19307738
9.

[Consensus on the medical treatment of gastrointestinal stromal tumors].

[No authors listed]

Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):875-7. Chinese. No abstract available.

PMID:
18396652
10.

Gastrointestinal stromal tumors: imatinib and beyond.

Schnadig ID, Blanke CD.

Curr Treat Options Oncol. 2006 Nov;7(6):427-37. Review.

PMID:
17032555
11.

Gastrointestinal stromal tumors (GISTs): a pathology view point.

Sornmayura P.

J Med Assoc Thai. 2009 Jan;92(1):124-35. Review.

PMID:
19260254
12.

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.

Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.

Anticancer Drugs. 2008 Jul;19(6):607-12. doi: 10.1097/CAD.0b013e32830138f9.

PMID:
18525320
13.

Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital.

Yeh CN, Chen TW, Lee HL, Liu YY, Chao TC, Hwang TL, Jan YY, Chen MF.

Ann Surg Oncol. 2007 Mar;14(3):1123-8. Epub 2006 Dec 31.

PMID:
17195905
14.

Update on the biology and therapy of gastrointestinal stromal tumors.

D'Amato G, Steinert DM, McAuliffe JC, Trent JC.

Cancer Control. 2005 Jan-Feb;12(1):44-56. Review.

15.

The role of KIT in the management of patients with gastrointestinal stromal tumors.

Hornick JL, Fletcher CD.

Hum Pathol. 2007 May;38(5):679-87. Review.

PMID:
17437861
16.

[Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)].

Mac K, Wójcik M.

Postepy Hig Med Dosw (Online). 2007 Jun 9;62:272-81. Review. Polish.

17.

Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.

Prior JO, Montemurro M, Orcurto MV, Michielin O, Luthi F, Benhattar J, Guillou L, Elsig V, Stupp R, Delaloye AB, Leyvraz S.

J Clin Oncol. 2009 Jan 20;27(3):439-45. doi: 10.1200/JCO.2008.17.2742. Epub 2008 Dec 8.

18.

[A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].

Miyake M, Takeda Y, Hasuike Y, Kashiwazaki M, Mishima H, Ikenaga M, Mano M, Takada Y, Hirota S, Tsujinaka T.

Gan To Kagaku Ryoho. 2004 Oct;31(11):1791-4. Japanese.

PMID:
15553717
19.
20.

Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.

Kitamura Y, Hirota S, Nishida T.

Cancer Sci. 2003 Apr;94(4):315-20. Review. Erratum in: Cancer Sci. 2003 Oct;94(10):930.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk